Profile avatar
alecgaffney.bsky.social
Executive Director, Regulatory Policy & Intelligence at POLITICO's AgencyIQ. Writing about how the FDA regulates medical products for 15+ years. Author of the newsletter 'FDA Today'. Signal: AlecGaffney.01
68 posts 1,280 followers 112 following
Regular Contributor
Active Commenter

There has been considerable focus in recent weeks about the impact of firing probationary employees at the FDA. But that's just the tip of the iceberg. I've assembled a list of all the other cuts that are coming next. It's a LONG list. (Free read) www.agencyiq.com/blog/a-guide...

In other news: I'm hiring. My team at AgencyIQ is growing, and I'm looking for a director to lead an existing team of chemicals regulatory analysts and prepare to grow a new team of food regulatory analysts. recruiting.ultipro.com/PER1013PCLL/...

Hearing from FDA staff that layoffs are hitting the agency this evening. One manager told me they don’t even know which of their staff is affected, and supervisors and office directors don’t have that information, either. Not clear yet if user fee-funded staff are affected.

FDA staff are about to come under pressure like never before as the Trump administration and Congress look to make federal agencies leaner. A new piece I published this morning has a thorough accounting of the pressures they'll face. www.agencyiq.com/blog/as-gove...

A scoop from AgencyIQ: The FDA this weekend modified the forms it uses to collect adverse event reports from the public, doctors and sponsors. The changes were made to remove any mention of gender. www.agencyiq.com/blog/fda-upd...

Anti-abortion groups have convinced lawmakers in several states, without evidence that abortion pills are contaminating the water supply. They also have plans for lawsuits & federal legislation cutting off access. They are comparing themselves to Erin Brockovich. www.politico.com/news/2025/01...

Some companies might want to update their training and SOPs in 2025 to instruct their management staff to not *fight the FDA inspectors* coming to their facility. One of the wildest warning letters I've ever read: www.fda.gov/inspections-...

With news today about how RFK allies have petitioned FDA to revoke approval for the polio vaccine, it's a good time to read my in-depth analysis of all the various mechanisms that RFK and his allies could potentially use to disrupt vaccine regulation at the FDA. 👇 www.agencyiq.com/blog/the-tru...

I would caution that these data are essentially garbage since the poll didn't even ask respondents if they knew who these people were. The questions they asked: www.ipsos.com/sites/defaul...

There's a portion of this TIME Magazine interview with Donald Trump that talks about vaccines, and it's.... not comforting for public health and regulatory officials. time.com/7201565/pers...

Yeah, so one of the groups in here is the Reagan-Udall Foundation for the FDA, which spearheaded major work which just resulted in FDA overhauling its human foods program to enable a closer look at food chemical safety - a major priority of MAHA.

I've been pretty underwhelmed by the sophistication of some of the analysis I've seen about what RFK Jr. could mean for FDA's regulation of vaccine products, so I decided to do something about it. Free to read, and explains how FDA actually works. www.agencyiq.com/blog/the-tru...

Well, that does not sound good at all... www.reuters.com/business/hea...

And for AgencyIQ subscribers, I have an in-depth look at all the ways that RFK Jr. could potentially use FDA authority to disrupt how vaccines are regulated. This piece is considerably more nuanced than any other I have seen to date: home.agencyiq.com/article/0000...

Something I've been spending a lot of time thinking about lately is how DOGE - the Department of Government Efficiency - could have an outsized impact on the FDA. I tracked down a *lot* of Ramaswamy and Musk's old posts and statements about the FDA to explain: www.agencyiq.com/blog/the-tru...

The Supreme Court today is hearing the case of FDA v. Wages and White Lion Investments, which focuses on FDA's regulation of ecigarettes. But as I explained in early September, the life sciences industry should pay close attention to this case, too. www.agencyiq.com/blog/e-cigar...

The amusing part about this (to me, at least) is that MAHA's regulatory philosophy is *markedly* different than the one espoused by O'Neill and other libertarians. Hard to imagine how "regulate this way more" and "regulate this way less" approaches work together here.

A dynamic to watch... unclear if this is speaking about potential FDA Commissioner pick Makary, or other folks within HHS (like Assistant Secretary at HHS).

Strong agree with this take. There's only so much attention in Washington. A key question is whether the focus remains on Justice-related appointees, or if it shifts to RFK, Hegseth, and other nominees.

I think at this point, FDA folks should just assume that whoever is nominated to be the next FDA Commissioner is going to be a controversial pick, and likely someone best known for their television presence. www.politico.com/news/2024/11...

The Trump transition is closing in on a number of names for top health posts across HHS. w/ @adamcancryn.bsky.social www.politico.com/news/2024/11...

A new FDA Warning Letter today to an Indian drug manufacturer is one for the ages. I mean, who among us doesn't hide batch production records on the roof during an FDA inspection? www.fda.gov/inspections-...

Some groups are keeping their metaphorical powder dry for now on Trump's intended nominee for HHS Secretary, Robert F. Kennedy Jr. But not everyone. My POLITICO colleague @meganmesserly.bsky.social reports that some Dem-aligned groups are assembling a "war room." www.politico.com/live-updates...

While much of what I (and my phenomenal team) at AgencyIQ write is behind a paywall, we have released a few of our election-related insights to our website. Read all about Trump and RFK's impact on user fees, HHS authority, and the incoming MAGA v. MAHA fight. www.agencyiq.com/blog/the-tru...

Drops in drug overdose deaths may mostly be thanks to... the very cartels supplying the drugs in the first place? A fascinating find here from my POLITICO colleague Carmen Paun: www.politico.com/newsletters/...